Who Just RaisedHoboken, NJ · Health Care · Form D filed Aug 10, 2026
Bullseye Biodevices, Inc. raised $1.3M
Bullseye Biodevices, Inc. is a biotechnology company based in Hoboken, New Jersey. In a Form D filed with the SEC on August 10, 2026, it reported raising $1,299,999 from 1 investor as part of an offering of up to $1,299,999. The first sale in the offering took place on July 28, 2026.
Bullseye Biodevices offers innovative biosensing devices for disease diagnosis. Explore our services, products, and expertise to advance your projects.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
$1.3M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 10, 2026 | $1.3M | $1.3M | 1 |
Lead score
33 out of 100
first raise ever budget to spend website found young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- bullseyebiodevices.com
- Amount raised
- $1,299,999
- Offering size
- $1,299,999
- Investors so far
- 1
- First sale
- July 28, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Hoboken, New Jersey
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $1,299,999 | $1,299,999 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 10, 2026 · Health Care funding in New Jersey · August 2026 funding report
Similar raises
Chicago Football Club P.B.C.
Hoboken, NJ · filed Sep 163rd Form D since 2023
Truespire Systems, Inc.
Hoboken, NJ · filed Sep 4First Form DStill raising
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Surgical Center of South Jersey LP
Mt. Laurel, NJ · filed Oct 811th Form D since 2010Still raising
Xenon Ophthalmics Inc
Jersey City, NJ · filed Oct 62nd Form D since 2023
Lisata Therapeutics, Inc.
Basking Ridge, NJ · filed Oct 2
Clinical-stage biopharmaceutical company developing therapies for solid tumors, including cancer drugs designed to improve delivery into tumor tissue.
8th Form D since 2014
Morris County Surgical Center, LLC
Parsippany, NJ · filed Sep 283rd Form D since 2021Still raising
Acuitive Technologies, Inc.
Allendale, NJ · filed Sep 244th Form D since 2021Still raising